|
||||||
Executive Summary Summary Innovus Pharmaceuticals Inc (Innovus Pharmaceuticals), formerly North Horizon Inc is a pharmaceutical company that commercialize, license and develops over-the-counter and consumer healthcare products. The company's product portfolio comprises BTH testosterone booster; Zestra for female arousal; EjectDelay for premature ejaculation; FlutiCare OTC for Allergic Rhinitis; and Sensum for the indication of reduced penile sensitivity. Innovus Pharmaceuticals offers its products for men's and women's health, vitality, sexual and reproductive health, pain, vision and respiratory disease. The company provides its products to urologists, primary care physicians, gynecologists, therapists and directly to consumers through on-line channels, retailers and wholesalers. Innovus Pharmaceuticals is headquartered in San Diego, California, the US. Innovus Pharmaceuticals Inc (INNV)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector. Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios. Business Description-A brief description of the company's operations. Key Employees-A list of the key executives of the company. Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors-A list of the key competitors of the company. Key Recent Developments-A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Read More Contact Us:
Table of Contents Table of Contents List of Tables List of Figures Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 Innovus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details Asset Purchase Innovus Pharma Acquires Assets of Beyond Human for USD0.6 Million Innovus Pharma Acquires Vesele from Trophikos Innovus Pharma Amends Acquisition of Rights to Circumserum from Centric Research for up to USD7.5 Million Innovus Pharma To Acquire Prescription Product Portfolio From Prospector Capital Partners II Venture Financing Innovus Pharma Raises USD0.33 Million In Venture Financing Innovus Pharma To Raise USD1.1 Million In Venture Financing Partnerships Innovus Pharma Enters into Distribution Agreement with Laboratorios Q Pharma Innovus Pharma Enters into Co-Marketing Agreement with DanaLife for Zestra Innovus Pharma Enters Into Co-Promotion Agreement With Consortia Health For EjectDelay Licensing Agreements Innovus Pharma Enters into License and Distribution Agreement with Lavasta Pharma Corporacion Pharma Solutions Peru Enters into Licensing Agreement with Innovus Pharma Innovus Pharma Plans to Enter into Licensing Agreement with University of Iowa Research Foundation Luminarie Enters into Licensing Agreement with Innovus Pharma Innovus Pharma Expands Licensing Agreement with Densmore for Zestra Innovus Pharma Enters into Licensing Agreement with NTC Innovus Pharma Enters into Licensing Agreement with J&H Co. for Zestra Elis Pharma Enters into Licensing Agreement with Innovus Pharma for Zestra Innovus Pharma Enters into Licensing Agreement with Seipel Innovus Pharma Enters into Licensing Agreement with BroadMed for EjectDelay Khandelwal Labs Enters into Licensing Agreement with Innovus Pharma BroadMed Enters into Licensing Agreement with Innovus Pharma for Sensum+ Innovus Pharma Enters Into License And Distribution Agreement With Ovation Pharma For Circumserum Acerus Pharma Enters into Licensing and Distribution Agreement with Innovus Pharma Bio Task Enters into Licensing Agreement with Innovus Pharma Elis Pharma Enters into Licensing Agreement with Innovus Pharma Innovus Pharma Enters into Licensing Agreement with Tabuk Pharma Innovus Pharma Enters into Licensing Agreement with Sothema Labs Orimed Pharma Expands Licensing Agreement with Innovus Pharma Innovus Pharma Enters into Licensing Agreement with Tramorgan for Sensum+ Innovus Pharma Enters Into Licensing Agreement With Ovation Pharma For EjectDelay Equity Offering Innovus Pharma Raises Funds through Private Placement Innovus Pharma Prices Public Offering of Shares for USD3.9 Million Innovus Pharma Files Registration Statement for Public Offering of Shares and Warrants for up to USD5 Million Innovus Pharma to Raise Funds in Public Offering of Shares Innovus Pharma to Raise USD0.2 Million in Private Placement of Shares upon Exercise of Warrants Innovus Pharma Completes Private Placement Of Shares For USD0.13 Million Innovus Pharma Completes Private Placement Of Shares For USD0.45 Million Innovus Pharma Completes Private Placement Of Shares For USD4.5 Million Debt Offering Innovus Pharma Raises USD0.8 Million in Third and Final Tranche of Private Placement of 10% Notes Due 2017 Innovus Pharma Raises Additional USD0.75 Million in Private Placement of 10% Note Due 2017 Innovus Pharma Raises USD1.5 Million in Private Placement of 10% Note Due 2017 Innovus Pharma Raises USD0.5 Million in Private Placement of 5% Notes Due 2016 Innovus Pharma to Raise USD0.3 Million Private Placement of 5% Notes Due 2016 Innovus Pharma to Raise USD0.3 Million Private Placement of 5% Notes Due 2016 Innovus Pharma Raises USD0.1 Million in Private Placement of Notes Innovus Pharma Raises USD0.1 Million in Private Placement of 8% Debentures Innovus Pharma Amends Private Placement of 8% Debenture Due 2016 Innovus Pharma Raises USD0.3 Million in Private Placement of 10% Debentures due 2015 Innovus Pharma Raises USD0.4 Million in Private Placement of 8% Debentures due 2014 Innovus Pharma Raises USD0.1 Million in Private Pacement of Convertible Debt Innovus Pharma Raises USD0.2 Million in Private Placement of 8% Debentures Asset Transactions Apricus Biosciences Acquires Remaining 50% Stake Of Rights To PrevOnco From Innovus Pharma Acquisition Innovus Pharma Acquires Novalere Innovus Pharma Acquires Semprae Labs Innovus Pharmaceuticals Inc-Key Competitors Innovus Pharmaceuticals Inc-Key Employees Innovus Pharmaceuticals Inc-Locations And Subsidiaries Head Office Other Locations & Subsidiaries Recent Developments Financial Announcements Nov 14, 2017: Innovus Pharmaceuticals Reports Nine Month Net Revenue of $6.4 million and Net Loss Decrease of 51.6% Compared to the Same Period in 2016 Aug 14, 2017: Innovus Pharmaceuticals Reports a Quarterly Net Revenue Increase of 99.2% and Net Loss Decrease of 74.1% Compared to the Same Period in 2016 May 12, 2017: Innovus Pharmaceuticals Reports Quarterly Revenue for the First Quarter 2017 of $2.2 Million Mar 06, 2017: Innovus Pharmaceuticals Reports Record Annual Revenues for the Full Year 2016 of $4.8 Million Legal and Regulatory Dec 04, 2017: Innovus Pharma Files Application for the Commercialization of ProstaGorx for Benign Prostatic Hyperplasia ("BPH") as a Natural Health Product in Canada Oct 18, 2017: Innovus Pharma Receives Approval from Health Canada for Vesele as a Natural Health Product Product News Nov 14, 2017: Innovus Pharma Launches FlutiCare OTC Nasal Spray Allergy Relief in the U.S. Sep 19, 2017: Innovus Pharma Announces the Launch of Zestra in France, Belgium and Monaco by Its Partner, Densmore Jun 01, 2017: Innovus Pharma Announces Positive Pre-Clinical Synergistic Effects of Vesele in Combination with Sildenafil on Nitric Oxide Production May 24, 2017: Innovus Pharma Launches AllerVarx, a Clinically Proven Supplement for the Relief of Allergy Symptoms, in the United States May 01, 2017: Innovus Pharma Launches ProstaGorx Product for Prostate Health Through its Beyond Human Sales and Marketing Platform in the United States Other Significant Developments Jan 18, 2018: Innovus Pharma Announces Official Launch of its Amazon, Walmart, eBay and Wish On-Line Stores with a Combined 116 Product SKUs Aug 09, 2017: Innovus Pharma Orders its First Commercial Batch of 220,000 Units of FlutiCare Apr 05, 2017: Innovus Pharma Announces Receipt of Notification to Commercialize Zestra Glide in the European Union 9 Mar 02, 2017: Innovus Pharma Announces Receipt of Notification to Commercialize Zestra in the European Union Appendix Methodology About GlobalData Contact Us Disclaimer List of Figures Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 Innovus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 List of Tables Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 Innovus Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 Innovus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 Innovus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 Innovus Pharma Acquires Assets of Beyond Human for USD0.6 Million Innovus Pharma Acquires Vesele from Trophikos Innovus Pharma Amends Acquisition of Rights to Circumserum from Centric Research for up to USD7.5 Million Innovus Pharma To Acquire Prescription Product Portfolio From Prospector Capital Partners II Innovus Pharma Raises USD0.33 Million In Venture Financing Innovus Pharma To Raise USD1.1 Million In Venture Financing Innovus Pharma Enters into Distribution Agreement with Laboratorios Q Pharma Innovus Pharma Enters into Co-Marketing Agreement with DanaLife for Zestra Innovus Pharma Enters Into Co-Promotion Agreement With Consortia Health For EjectDelay Innovus Pharma Enters into License and Distribution Agreement with Lavasta Pharma Corporacion Pharma Solutions Peru Enters into Licensing Agreement with Innovus Pharma Innovus Pharma Plans to Enter into Licensing Agreement with University of Iowa Research Foundation Luminarie Enters into Licensing Agreement with Innovus Pharma Innovus Pharma Expands Licensing Agreement with Densmore for Zestra Innovus Pharma Enters into Licensing Agreement with NTC Innovus Pharma Enters into Licensing Agreement with J&H Co. for Zestra Elis Pharma Enters into Licensing Agreement with Innovus Pharma for Zestra Innovus Pharma Enters into Licensing Agreement with Seipel Innovus Pharma Enters into Licensing Agreement with BroadMed for EjectDelay Khandelwal Labs Enters into Licensing Agreement with Innovus Pharma BroadMed Enters into Licensing Agreement with Innovus Pharma for Sensum+ Innovus Pharma Enters Into License And Distribution Agreement With Ovation Pharma For Circumserum Acerus Pharma Enters into Licensing and Distribution Agreement with Innovus Pharma Bio Task Enters into Licensing Agreement with Innovus Pharma Elis Pharma Enters into Licensing Agreement with Innovus Pharma Innovus Pharma Enters into Licensing Agreement with Tabuk Pharma Innovus Pharma Enters into Licensing Agreement with Sothema Labs Orimed Pharma Expands Licensing Agreement with Innovus Pharma Innovus Pharma Enters into Licensing Agreement with Tramorgan for Sensum+ Innovus Pharma Enters Into Licensing Agreement With Ovation Pharma For EjectDelay Innovus Pharma Raises Funds through Private Placement Innovus Pharma Prices Public Offering of Shares for USD3.9 Million Innovus Pharma Files Registration Statement for Public Offering of Shares and Warrants for up to USD5 Million Innovus Pharma to Raise Funds in Public Offering of Shares Innovus Pharma to Raise USD0.2 Million in Private Placement of Shares upon Exercise of Warrants Innovus Pharma Completes Private Placement Of Shares For USD0.13 Million Innovus Pharma Completes Private Placement Of Shares For USD0.45 Million Innovus Pharma Completes Private Placement Of Shares For USD4.5 Million Innovus Pharma Raises USD0.8 Million in Third and Final Tranche of Private Placement of 10% Notes Due 2017 Innovus Pharma Raises Additional USD0.75 Million in Private Placement of 10% Note Due 2017 Innovus Pharma Raises USD1.5 Million in Private Placement of 10% Note Due 2017 Innovus Pharma Raises USD0.5 Million in Private Placement of 5% Notes Due 2016 Innovus Pharma to Raise USD0.3 Million Private Placement of 5% Notes Due 2016 Innovus Pharma to Raise USD0.3 Million Private Placement of 5% Notes Due 2016 Innovus Pharma Raises USD0.1 Million in Private Placement of Notes Innovus Pharma Raises USD0.1 Million in Private Placement of 8% Debentures Innovus Pharma Amends Private Placement of 8% Debenture Due 2016 Innovus Pharma Raises USD0.3 Million in Private Placement of 10% Debentures due 2015 Innovus Pharma Raises USD0.4 Million in Private Placement of 8% Debentures due 2014 Innovus Pharma Raises USD0.1 Million in Private Pacement of Convertible Debt Innovus Pharma Raises USD0.2 Million in Private Placement of 8% Debentures Apricus Biosciences Acquires Remaining 50% Stake Of Rights To PrevOnco From Innovus Pharma Innovus Pharma Acquires Novalere Innovus Pharma Acquires Semprae Labs Innovus Pharmaceuticals Inc, Key Competitors Innovus Pharmaceuticals Inc, Key Employees Innovus Pharmaceuticals Inc, Subsidiaries Single User License: Site License: Corporate User License: |
select a license |
||
NEWSLETTER BY CATEGORY
|
||
Testimonials
|
||
The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center" |